Medicina
Facultad
Montreal Heart Institute
Montreal, CanadáPublicaciones en colaboración con investigadores/as de Montreal Heart Institute (39)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis
Cardiovascular Diabetology, Vol. 22, Núm. 1
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 9, Núm. 4, pp. 353-370
-
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 6, pp. 570-582
2021
-
Differences in platelet-rich plasma composition influence bone healing
Journal of Clinical Periodontology, Vol. 48, Núm. 12, pp. 1613-1623
2019
-
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study
Journal of the American College of Cardiology, Vol. 73, Núm. 6, pp. 629-638
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
2015
2014
-
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: A prospective analysis of 22,272 patients
PLoS ONE, Vol. 9, Núm. 7
-
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: Findings from the international prospective CLARIFY registry
International Journal of Cardiology, Vol. 176, Núm. 1, pp. 119-124
2013
-
Relationship of Quality of Life With Procedural Success of Atrial Fibrillation (AF) Ablation and Postablation AF Burden: Substudy of the STAR AF Randomized Trial
Canadian Journal of Cardiology, Vol. 29, Núm. 10, pp. 1211-1217
2012
-
Incidence and significance of early recurrences associated with different ablation strategies for AF: A STAR-AF substudy
Journal of Cardiovascular Electrophysiology, Vol. 23, Núm. 12, pp. 1295-1301
-
Non-invasive imaging in acute chest pain syndromes
European Heart Journal Cardiovascular Imaging, Vol. 13, Núm. 1, pp. 69-78
-
Vorapaxar in the secondary prevention of atherothrombotic events
New England Journal of Medicine, Vol. 366, Núm. 15, pp. 1404-1413
2011
-
Differential effectiveness of pharmacological strategies to reveal dormant pulmonary vein conduction: A clinical-experimental correlation
Heart Rhythm, Vol. 8, Núm. 9, pp. 1426-1433
2010
-
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243
-
Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins
Circulation, Vol. 121, Núm. 8, pp. 963-972
-
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): A randomized, multicentre, international trial
European Heart Journal, Vol. 31, Núm. 11, pp. 1344-1356
2009
-
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091
-
The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
American Heart Journal, Vol. 158, Núm. 2, pp. 201.e5